Bethesda Assay for Detecting Inhibitory Anti-ADAMTS13 Antibodies in Immune-Mediated Thrombotic Thrombocytopenic Purpura
A diagnosis of thrombotic thrombocytopenic purpura (TTP) is confirmed by a severe deficiency (<10%) of a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) activity. Autoantibodies to ADAMTS13 can be detected with a simplified enzyme-linked immunosorbent as...
Main Authors: | Chiara Vendramin, Mari Thomas, John-Paul Westwood, Marie Scully |
---|---|
Format: | Article |
Language: | English |
Published: |
Georg Thieme Verlag KG
2018-07-01
|
Series: | TH Open |
Subjects: | |
Online Access: | http://www.thieme-connect.de/DOI/DOI?10.1055/s-0038-1672187 |
Similar Items
-
Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura
by: Mari R. Thomas, et al.
Published: (2015-08-01) -
Clinical observation of a patient with thrombotic thrombocytopenic purpura with renal and intestinal lesions
by: A G Stolyar, et al.
Published: (2019-07-01) -
Diagnosis and follow‐up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay
by: Nicolas Beranger, et al.
Published: (2021-01-01) -
Diagnosis of thrombotic thrombocytopenic purpura
by: G. M. Galstyan, et al.
Published: (2020-12-01) -
Treatment of thrombotic thrombocytopenic purpura
by: Gennadii M. Galstyan, et al.
Published: (2021-07-01)